146 related articles for article (PubMed ID: 27311399)
1. Cervical nodal level V can safely be omitted in the treatment of locally advanced oropharyngeal squamous cell carcinoma with definitive IMRT.
Gutiontov S; Leeman J; Lok B; Romesser P; Riaz N; Tsai CJ; Lee N; McBride S
Oral Oncol; 2016 Jul; 58():27-31. PubMed ID: 27311399
[TBL] [Abstract][Full Text] [Related]
2. Sparing bilateral neck level IB in oropharyngeal carcinoma and xerostomia outcomes.
Tam M; Riaz N; Kannarunimit D; Peña AP; Schupak KD; Gelblum DY; Wolden SL; Rao S; Lee NY
Am J Clin Oncol; 2015 Aug; 38(4):343-7. PubMed ID: 26208401
[TBL] [Abstract][Full Text] [Related]
3. Sparing of high retropharyngeal nodal basins in patients with unilateral oropharyngeal carcinoma treated with intensity modulated radiation therapy.
Leeman JE; Gutiontov S; Romesser P; McBride S; Riaz N; Lee N; Tsai CJ
Pract Radiat Oncol; 2017; 7(4):254-259. PubMed ID: 28094212
[TBL] [Abstract][Full Text] [Related]
4. Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume.
Chao KS; Ozyigit G; Blanco AI; Thorstad WL; Deasy JO; Haughey BH; Spector GJ; Sessions DG
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):43-50. PubMed ID: 15093897
[TBL] [Abstract][Full Text] [Related]
5. Target volume definition for intensity-modulated radiotherapy after induction chemotherapy and patterns of treatment failure after sequential chemoradiotherapy in locoregionally advanced oropharyngeal squamous cell carcinoma.
Loo SW; Geropantas K; Wilson P; Martin WM; Roques TW
Clin Oncol (R Coll Radiol); 2013 Mar; 25(3):162-70. PubMed ID: 22906546
[TBL] [Abstract][Full Text] [Related]
6. Selective omission of level V nodal coverage for patients with oropharyngeal cancer: Clinical validation of intensity-modulated radiotherapy experience and dosimetric significance.
Mohindra P; Urban E; Pagan JD; Geye HM; Patel VB; Bayliss RA; Bender ET; Harari PM
Head Neck; 2016 Apr; 38(4):499-505. PubMed ID: 25445257
[TBL] [Abstract][Full Text] [Related]
7. Patterns of regional lymph node failure of locally advanced hypopharyngeal squamous cell carcinoma after first-line treatment with surgery and/or intensity-modulated radiotherapy.
Wang D; Yu S; Zhai L; Xu J; Li B
BMC Cancer; 2020 Apr; 20(1):283. PubMed ID: 32252691
[TBL] [Abstract][Full Text] [Related]
8. Recurrent oropharyngeal cancer after organ preserving treatment: pattern of failure and survival.
de Ridder M; Gouw ZAR; Sonke JJ; Navran A; Jasperse B; Heukelom J; Tesselaar MET; Klop WMC; van den Brekel MWM; Al-Mamgani A
Eur Arch Otorhinolaryngol; 2017 Mar; 274(3):1691-1700. PubMed ID: 27942891
[TBL] [Abstract][Full Text] [Related]
9. Intensity-modulated radiation therapy in oropharyngeal carcinoma: effect of tumor volume on clinical outcomes.
Lok BH; Setton J; Caria N; Romanyshyn J; Wolden SL; Zelefsky MJ; Park J; Rowan N; Sherman EJ; Fury MG; Ho A; Pfister DG; Wong RJ; Shah JP; Kraus DH; Zhang Z; Schupak KD; Gelblum DY; Rao SD; Lee NY
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1851-7. PubMed ID: 21640497
[TBL] [Abstract][Full Text] [Related]
10. Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Oropharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy.
Youssef I; Yoon J; Mohamed N; Zakeri K; Press RH; Chen L; Gelblum DY; McBride SM; Tsai CJ; Riaz N; Yu Y; Cohen MA; Dunn LA; Ho AL; Wong RJ; Michel LS; Boyle JO; Singh B; Kriplani A; Ganly I; Sherman EJ; Pfister DG; Fetten J; Lee NY
JAMA Netw Open; 2022 Nov; 5(11):e2241538. PubMed ID: 36367724
[TBL] [Abstract][Full Text] [Related]
11. [Impact of neck dissection in N2-3 oropharyngeal squamous cell carcinomas treated with definitive chemoradiotherapy: An observational real-life study].
Klausner G; Troussier I; Kreps S; Fabiano E; Laccourreye O; Giraud P
Cancer Radiother; 2021 Dec; 25(8):771-778. PubMed ID: 34175226
[TBL] [Abstract][Full Text] [Related]
12. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience.
de Arruda FF; Puri DR; Zhung J; Narayana A; Wolden S; Hunt M; Stambuk H; Pfister D; Kraus D; Shaha A; Shah J; Lee NY
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):363-73. PubMed ID: 15925451
[TBL] [Abstract][Full Text] [Related]
13. Radiographic retropharyngeal lymph node involvement in HPV-associated oropharyngeal carcinoma: Patterns of involvement and impact on patient outcomes.
Lin TA; Garden AS; Elhalawani H; Elgohari B; Jethanandani A; Ng SP; Mohamed AS; Frank SJ; Glisson BS; Debnam JM; Sturgis EM; Phan J; Reddy JP; Fuller CD; Morrison WH; Skinner HD; Rosenthal DI; Gunn GB
Cancer; 2019 May; 125(9):1536-1546. PubMed ID: 30620385
[TBL] [Abstract][Full Text] [Related]
14. Intensity-modulated radiotherapy for oropharyngeal squamous cell carcinoma.
Mendenhall WM; Amdur RJ; Morris CG; Kirwan JM; Li JG
Laryngoscope; 2010 Nov; 120(11):2218-22. PubMed ID: 20938964
[TBL] [Abstract][Full Text] [Related]
15. Radiotherapy for Oropharyngeal Carcinoma With an Uninvolved Contralateral Neck: The Safety of Omission of Contralateral High Level II and Retropharyngeal Lymph Nodes From Elective Target Volumes.
Iyizoba-Ebozue Z; Murray LJ; Ramasamy S; Sen M; Murray P; Cardale K; Dyker K; Prestwich RJD
Clin Oncol (R Coll Radiol); 2021 May; 33(5):331-339. PubMed ID: 33358282
[TBL] [Abstract][Full Text] [Related]
16. Patterns of Treatment Failure and Postrecurrence Outcomes Among Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma After Chemoradiotherapy Using Modern Radiation Techniques.
Leeman JE; Li JG; Pei X; Venigalla P; Zumsteg ZS; Katsoulakis E; Lupovitch E; McBride SM; Tsai CJ; Boyle JO; Roman BR; Morris LGT; Dunn LA; Sherman EJ; Lee NY; Riaz N
JAMA Oncol; 2017 Nov; 3(11):1487-1494. PubMed ID: 28542679
[TBL] [Abstract][Full Text] [Related]
17. Patterns of Recurrence in Electively Irradiated Lymph Node Regions After Definitive Accelerated Intensity Modulated Radiation Therapy for Head and Neck Squamous Cell Carcinoma.
van den Bosch S; Dijkema T; Verhoef LC; Zwijnenburg EM; Janssens GO; Kaanders JH
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):766-74. PubMed ID: 26972649
[TBL] [Abstract][Full Text] [Related]
18. Submandibular gland-sparing radiation therapy for locally advanced oropharyngeal squamous cell carcinoma: patterns of failure and xerostomia outcomes.
Gensheimer MF; Liao JJ; Garden AS; Laramore GE; Parvathaneni U
Radiat Oncol; 2014 Nov; 9():255. PubMed ID: 25424729
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Substantial Reduction in Elective Radiotherapy Dose and Field in Patients With Human Papillomavirus-Associated Oropharyngeal Carcinoma Treated With Definitive Chemoradiotherapy.
Tsai CJ; McBride SM; Riaz N; Kang JJ; Spielsinger DJ; Waldenberg T; Gelblum D; Yu Y; Chen LC; Zakeri K; Wong RJ; Dunn L; Pfister DG; Sherman EJ; Lee NY
JAMA Oncol; 2022 Mar; 8(3):364-372. PubMed ID: 35050342
[TBL] [Abstract][Full Text] [Related]
20. Survival outcomes in patients with oropharyngeal cancer treated with carboplatin/paclitaxel and concurrent radiotherapy.
Roskies M; Kay-Rivest E; Mascarella MA; Sultanem K; Mlynarek A; Hier M
J Otolaryngol Head Neck Surg; 2016 Oct; 45(1):50. PubMed ID: 27724969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]